Stay updated on Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, making the record inaccessible. The visible additions include a 403 header and a Home button, signaling an access issue rather than a change to trial data.
    Difference
    21%
    Check dated 2026-09-19T18:44:04.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page was updated to revision v3.6.6, replacing the previous v3.6.5. This appears to be an internal update to the page version and does not modify the study details or visible content.
    Difference
    0.0%
    Check dated 2026-08-29T19:26:26.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    A newer revision label (v3.6.5) is shown, indicating a site update; the core study information remains unchanged.
    Difference
    0.0%
    Check dated 2026-08-08T10:36:06.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The study record now lists UPMC Hillman Cancer Center as a participating site, replacing University of Pittsburgh Cancer Institute (UPCI). This reflects an organizational naming update and a new revision of the study record (v3.6.4).
    Difference
    0.2%
    Check dated 2026-08-01T09:28:50.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3. This signifies a new page version for maintenance or updates, without changing the substantive study information.
    Difference
    0.0%
    Check dated 2026-07-03T23:01:00.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, indicating a maintenance update to the page. This change does not alter the study details, eligibility criteria, or outcomes presented on the page.
    Difference
    0.0%
    Check dated 2026-06-26T23:47:36.000Z thumbnail image

Stay in the know with updates to Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.